These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 17120604)

  • 1. HIV infection among heroin users and area of residence.
    Long J; Keenan E; Grogan L; Mullen L; Barry J; Sinclair H
    Ir Med J; 2006 Sep; 99(8):230-3. PubMed ID: 17120604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
    AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between cocaine use and short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Williamson A; Darke S; Ross J; Teesson M
    Drug Alcohol Rev; 2006 Mar; 25(2):141-8. PubMed ID: 16627303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection among noninjecting drug users in New York City.
    Koblin BA; Factor SH; Wu Y; Vlahov D
    J Med Virol; 2003 Jul; 70(3):387-90. PubMed ID: 12767001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
    Cullen W; Stanley J; Langton D; Kelly Y; Bury G
    Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zopiclone misuse: an update from Dublin.
    Bannan N; Rooney S; O'connor J
    Drug Alcohol Rev; 2007 Jan; 26(1):83-5. PubMed ID: 17364840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in impulsivity and sexual risk behavior among inner-city crack/cocaine users and heroin users.
    Lejuez CW; Bornovalova MA; Daughters SB; Curtin JJ
    Drug Alcohol Depend; 2005 Feb; 77(2):169-75. PubMed ID: 15664718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs).
    Miller CL; Strathdee SA; Li K; Kerr T; Wood E
    Am J Drug Alcohol Abuse; 2007; 33(4):527-36. PubMed ID: 17668338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary cocaine use patterns and associated harms in Melbourne and Sydney, Australia.
    Shearer J; Johnston J; Fry CL; Kaye S; Dillon P; Dietze P; Collins L
    Drug Alcohol Rev; 2007 Sep; 26(5):537-43. PubMed ID: 17701517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus-2 and HIV among noninjecting drug users in New York city.
    Des Jarlais DC; Hagan H; Arasteh K; McKnight C; Perlman D; Friedman SR
    Sex Transm Dis; 2007 Nov; 34(11):923-7. PubMed ID: 18049425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Young adult injection drug users in the United States continue to practice HIV risk behaviors.
    Rondinelli AJ; Ouellet LJ; Strathdee SA; Latka MH; Hudson SM; Hagan H; Garfein RS
    Drug Alcohol Depend; 2009 Sep; 104(1-2):167-74. PubMed ID: 19559543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric comorbidity in young heroin users.
    Rodríguez-Llera MC; Domingo-Salvany A; Brugal MT; Silva TC; Sánchez-Niubó A; Torrens M;
    Drug Alcohol Depend; 2006 Sep; 84(1):48-55. PubMed ID: 16388919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid assessment of heroin use in Mombasa, Kenya.
    Beckerleg S; Telfer M; Sadiq A
    Subst Use Misuse; 2006; 41(6-7):1029-44. PubMed ID: 16809185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent classes of heroin and cocaine users predict unique HIV/HCV risk factors.
    Harrell PT; Mancha BE; Petras H; Trenz RC; Latimer WW
    Drug Alcohol Depend; 2012 May; 122(3):220-7. PubMed ID: 22030276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months: findings from the Australian Treatment Outcome Study.
    Williamson A; Darke S; Ross J; Teesson M
    J Subst Abuse Treat; 2007 Oct; 33(3):287-93. PubMed ID: 17889301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience of hepatitis C among current or former heroin users attending general practice.
    Cullen W; Kelly Y; Stanley J; Langton D; Bury G
    Ir Med J; 2005 Mar; 98(3):73-4. PubMed ID: 15869062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of 'visible' and 'invisible' users of amphetamine, cocaine and heroin: two distinct populations?
    Robson P; Bruce M
    Addiction; 1997 Dec; 92(12):1729-36. PubMed ID: 9581005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.
    Maher L; Li J; Jalaludin B; Wand H; Jayasuriya R; Dixon D; Kaldor JM
    Drug Alcohol Depend; 2007 Jul; 89(2-3):244-50. PubMed ID: 17289299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.